The FDA is expected to decide on treatments for COPD, psoriasis, rare neuroendocrine tumors, and a next-generation COVID-19 vaccine.
Some U.S. health regulators who review medical devices and tobacco products for safety and efficacy are struggling to meet ...
The FDA has approved a new at-home test for common sexually transmitted infections and diseases. The test for chlamydia, ...
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...
Vivex Biologics chairman John McCallum breaks down the challenges, costs, and strategies behind bringing medical innovations ...
Orthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial ...
In March 2025, Juventas Cell Therapy Ltd. conducted a phase Ib/II trial to evaluate the safety and efficacy of CNCT19 ...
Denmark's Bavarian Nordic said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its ...